Functional Service Provider (FSP)
Definition
A functional service provider (FSP) is a company that runs specific functions of clinical research, such as data management, biostatistics, clinical monitoring or pharmacovigilance, for a drug or device sponsor. Unlike a full-service CRO that runs entire studies, an FSP supplies dedicated teams for one function across a sponsor's portfolio of trials.
FSPs take on specific functions of clinical research, such as data management or biostatistics, so a sponsor gets specialist teams without handing over the whole study.
What is a functional service provider model?
In the FSP model, a biotech, pharmaceutical or device company outsources particular functions it needs for its trials, such as data management, biostatistics, clinical monitoring, regulatory affairs or pharmacovigilance, rather than an entire trial. The sponsor keeps more control over how the work is done and can scale each function up or down.
How does the FSP model benefit clinical research?
- Cost: sponsors pay only for the functions they need
- Flexibility: different providers can handle different functions
- Control: sponsors keep their own processes and oversight while adding capacity
How does an FSP differ from a traditional CRO?
A full-service contract research organization (CRO) runs entire clinical trials, from setup to final report. An FSP provides staff and expertise for specific functions inside the sponsor's own process. Many large CROs offer both models.
What the FSP model means for teams selling into healthcare
FSP deals are usually decided by the sponsor's clinical operations, data management or biostatistics leaders together with procurement and outsourcing teams. Vendors of trial software and services should map both the sponsor's functional leaders and the FSP partners they already use, because the FSP team often runs the tools day to day.
Terms related to Functional Service Provider
- FIPNETFully Integrated Pharmacy NetworkA fully integrated pharmaceutical network (FIPNet) is a business model in which a drug company keeps control of a product's strategy and key decisions while partners, such as contract research, manufacturing and sales organizations, carry out much of the research, development, manufacturing and commercial work.
- Key Opinion Leader (KOL) ManagementKey opinion leader (KOL) management is how pharmaceutical, biotech and medical device companies identify, engage and track relationships with influential clinicians and researchers.